Cargando…
Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
SIMPLE SUMMARY: Immunotherapy targeting immune checkpoints and stromal cells in the tumor microenvironment is currently one of the most promising directions for tumor therapy. Ongoing studies suggest that CD73 plays an important role in the tumor immune process in certain tumors, however, the exact...
Autores principales: | Tang, Kun, Zhang, Jingwei, Cao, Hui, Xiao, Gelei, Wang, Zeyu, Zhang, Xun, Zhang, Nan, Wu, Wantao, Zhang, Hao, Wang, Qianrong, Xu, Huilan, Cheng, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688912/ https://www.ncbi.nlm.nih.gov/pubmed/36428755 http://dx.doi.org/10.3390/cancers14225663 |
Ejemplares similares
-
The role of TGR5 as an onco-immunological biomarker in tumor staging and prognosis by encompassing the tumor microenvironment
por: Guan, Zhiyuan, et al.
Publicado: (2022) -
A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
por: Li, He, et al.
Publicado: (2022) -
The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning
por: Zhang, Nan, et al.
Publicado: (2021) -
CD73 in small extracellular vesicles derived from HNSCC defines tumour‐associated immunosuppression mediated by macrophages in the microenvironment
por: Lu, Tingwei, et al.
Publicado: (2022) -
Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)